Furthermore, as hypoxia has well-documented effects on cancer malignancy and resistance to chemotherapy (15), hypoxia inducible factor 1α (HIF-1α), a downstream protein of mTORC1 that regulates the expression of P-gp and MRP1, has emerged as an attractive target for cancer therapy (16). Here, PGP is linked to cancer.